<i>Candida glabrata</i> (<i>Nakaseomyces glabrata</i>): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List
Justin Beardsley(The University of Sydney), Jan‐Willem C. Alffenaar(The University of Sydney), Sarah Kidd(Laboratoire National de Référence), Tania C. Sorrell(The University of Sydney), Ana Alastruey‐Izquierdo(Instituto de Salud Carlos III), Arunaloke Chakrabarti(Dev Sanskriti Vishwavidyalaya), Felix Bongomin(University of Manchester), Valeria Gigante(World Health Organization), Thomas S. Harrison(Sheffield Teaching Hospitals NHS Foundation Trust), Aiken Dao(The University of Sydney), Felipe Roitberg(World Health Organization), Daniel Argaw Dagne(World Health Organization), Hannah Yejin Kim(The University of Sydney), Hatim Sati(World Health Organization), C. Orla Morrissey(Alfred Health), Siswanto Siswanto(World Health Organization Regional Office for South-East Asia), Evelina Tacconelli(World Health Organization), Marcelo Galas(World Health Organization Regional Office for the Americas)
Cited by 38
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
|Journal of Fungi|2017|2.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2010|2.7k